A phase 1 clinical trial of single-agent selinexor in acute myeloid leukemia.

Cite this paper

@article{Garzon2017AP1, title={A phase 1 clinical trial of single-agent selinexor in acute myeloid leukemia.}, author={Ramiro Garzon and Michael R Savona and Rachid Baz and Michael Andreeff and Nashat Y Gabrail and Martin E. Gutierrez and Lynn Savoie and Paul Morten Mau-Sorensen and Nina D. Wagner-Johnston and Karen W. L. Yee and Thaddeus John Unger and Jean-Richard Saint-Martin and Robert W. Carlson and Tami Rashal and Trinayan Kashyap and Boris S. Klebanov and Sharon Shacham and Michael G. Kauffman and Richard M Stone}, journal={Blood}, year={2017}, volume={129 24}, pages={3165-3174} }